Your legacy can help bring an end to CMT. Learn how a planned gift can make an impact for generations to come.
The CMTA Mourns the Loss of Scientific Advisory Board Member and Esteemed CMT Clinical Researcher
…Laura Feltri will be deeply missed.” Dr. Feltri was a dedicated supporter of our mission to support the development of new treatments for CMT, to improve the quality of life…
INC Research Study 6601
…progressed in people if the drug had not been administered. In essence, researchers are using this natural history to establish baselines against which the results of treatment regimens may be…
Managing Neuropathic Pain
…oral medications for the treatment of neuropathic pain are gabapentinoids (such as gabapentin and pregabalin), serotonin norepinephrine reuptake inhibitors (SNRIs such as duloxetine and venlafaxine), tricyclic antidepressants (TCAs such as…
CMTAreportFall2023Spreads
…further accelerate progress. The CMTA is committed to supporting clinical trial readiness and roll-out for CMT and we look forward to the next chapter of this treatment’s development.” DTx Pharma…
Foot and Hand Care
…muscles within the foot itself (intrinsic muscles) atrophy, and cause the toes to curl up. Treatment ranges from wearing insoles to surgery. Paralytic Flatfoot: A less common foot type, which…
What is CMT?
…legs, progressive sensory loss, and CMT can affect other parts of the body. This leads to problems with balance, walking, hand use, and more. There currently is no treatment or…
CMT4 Research
…IND submission process. Project Updated: February 18, 2025 CMTA-STAR Accelerates Progress Toward Transformative Treatments for CMT4C Through these ambitious efforts, CMTA-STAR is driving groundbreaking progress toward effective treatments for CMT4C…
Vera Fridman, MD joins the CMTA STAR Advisory Board
…on paving the way for, and executing, treatment trials for neuropathy. Dr. Fridman’s research aims to address the barriers to effective clinical trials in Charcot-Marie-Tooth (CMT) disease through the execution…
Gene Therapy Advances for CMT4J, CMT4A and GAN
…a gene therapy for one rare form of CMT called Giant Axonal Neuropathy, and aims to develop similar gene therapy treatments for other forms of CMT. Dr. Gray is a…
CMTA Lunch & Learn: Neuro-Toxic Medication List Update
07/13/2023 @ 12:00 pm – 1:00 pm – Please join us on July 13 at 12:00 p.m. Eastern Time to hear an update on the newly reviewed and revised CMT Neuro-toxic Medication List. The CMTA funded a grant awarded to Guido Cavaletti, MD at the University of Milano-Bicocca to review and update the current CMT neuro-toxic medication list. Dr. Cavaletti and colleague, Dr. […]